A Practice-Based Evaluation of Pocket Book Supported Pharmacist Education in Improving Quality of Life and Clinical Outcomes Among Prolanis Patients with Hypertension

Dewi Rahmawati; Sinta  Ariani; Adam M Ramadhan

doi:10.30872/jtpc.v9i2.301

Authors

Dewi Rahmawati Fakultas Farmasi Universitas Mulawarman Author
Sinta Ariani 3Clinical Pharmacy Study Program, Faculty of Pharmacy, Universitas Mulawarman, Samarinda, East Kalimantan Indonesia Author
Adam M Ramadhan Author

DOI:

https://doi.org/10.30872/jtpc.v9i2.301

Abstract

Hypertension remains a major public health burden globally and in Indonesia, and pharmacists play an essential role in optimizing antihypertensive therapy through structured education. This quasi-experimental one-group pretest–posttest study evaluated the effectiveness of pharmacist-led pocket book education on health-related quality of life (HRQoL) and blood pressure control among 40 Prolanis hypertensive patients at Juanda Public Health Center (January–February 2025). Participants received individualized counseling using a hypertension pocket book covering disease understanding, medication adherence, and lifestyle modification; HRQoL was assessed using the EQ-5D-5L Indonesian value set, while systolic and diastolic blood pressure served as clinical outcomes. Significant improvements were observed, with mean utility scores increasing from 0.824 ± 0.065 to 0.967 ± 0.020 (p < 0.001; d = 1.2), systolic blood pressure decreasing from 144.97 ± 17.42 to 137.87 ± 16.11 mmHg (p = 0.003), and diastolic blood pressure decreasing from 83.00 ± 8.75 to 79.72 ± 8.73 mmHg (p = 0.001). Regression analysis identified shorter hypertension duration and absence of comorbidity as significant predictors of HRQoL improvement (β = 0.34, p = 0.04). These findings demonstrate that pharmacist-led pocket book education is an effective, low-cost intervention with strong potential for broader implementation in primary care and Prolanis programs.

Downloads

Download data is not yet available.

References

[1] World Health Organization (WHO), Hypertension, 2023. [Online]. Available: www.who.int. [Accessed: 15-May-2025].

[2] Kementerian Kesehatan Badan Kebijakan Pembangunan Kesehatan, Survei Kesehatan Indonesia (SKI) 2023 dalam Angka, Jakarta: Kementerian Kesehatan, 2023.

[3] Dinas Kesehatan Provinsi Kalimantan Timur, Profil Kesehatan Tahun 2020, Samarinda: Dinkes Prov. Kaltim, 2021.

[4] K. Kartikasari, D. S. S. Rejeki, and S. Pramatama, “Faktor-faktor yang mempengaruhi tingkat kepatuhan pengobatan pada pasien hipertensi di berbagai wilayah Indonesia,” J. Pendidik. Tambusai, vol. 6, no. 2, pp. 11665–11676, 2022.

[5] J. Fernandes, M. Triharini, and E. M. M. Has, “Tingkat pengetahuan penderita hipertensi tentang kepatuhan berobat,” J. Telenursing, vol. 5, no. 1, pp. 162–172, 2023.

[6] I. Maf’ula, A. Zuhriyah, and A. Basith, “Evaluasi pemberian komunikasi, informasi dan edukasi (KIE) obat terhadap tingkat kepuasan konsumen,” J. Law Adm. Soc. Sci., vol. 3, no. 2, pp. 199–206, 2023.

[7] H. Pratiwi, N. Nuryanti, V. V. Fera, W. Warsinah, and N. K. Sholihat, “Pengaruh edukasi terhadap pengetahuan, sikap, dan kemampuan berkomunikasi atas informasi obat,” Kartika: J. Ilm. Farm., vol. 4, no. 1, pp. 10–15, 2016.

[8] A. Saputri and S. R. Rahayu, “Efektivitas Cepat Tensi terhadap peningkatan pengetahuan dan sikap pada wanita menopause,” J. Health Educ., vol. 2, no. 2, pp. 107–114, 2017.

[9] M. Hidayah and S. Sopiyandi, “Efektivitas buku saku dan leaflet terhadap pengetahuan dan kepatuhan diet pasien diabetes melitus tipe 2,” Pontianak Nutr. J., vol. 1, no. 2, pp. 66–69, 2019.

[10] T. D. S. Pratama, N. M. Yasin, and S. A. Kristina, “Pengaruh medication therapy management terhadap outcome klinik dan kualitas hidup pasien hipertensi,” J. Manaj. Pelayanan Farm., vol. 10, no. 4, pp. 261–275, 2021.

[11] F. D. Purba et al., “The Indonesian EQ-5D-5L value set,” Pharmacoeconomics, vol. 35, no. 11, pp. 1153–1165, 2017.

[12] E. E. Ayogu et al., “Effectiveness of a pharmacist-led educational intervention on health outcomes in hypertension management,” Br. J. Clin. Pharmacol., vol. 89, no. 2, pp. 649–659, 2023.

[13] F. Saleem et al., “Pharmacist intervention in improving hypertension-related knowledge, medication adherence and HRQoL,” Health Expect., vol. 18, no. 5, pp. 1270–1281, 2015.

[14] J. S. Soni et al., “Roles of pharmacists in optimizing care for hypertensive patients in hospital and community pharmacies,” East Cent. Afr. J. Pharm. Sci., vol. 23, pp. 28–35, 2020.

[15] Blood Pressure Lowering Treatment Trialists’ Collaboration, “Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease,” Lancet, vol. 397, no. 10285, pp. 1625–1636, 2021.

[16] L. Gultom and M. Pardosi, “Effectiveness of pocket book use in hypertension control,” Int. J. Sci. Res., vol. 6, no. 11, pp. 32–35, 2018.

[17] Tam H. L., Wong E. M. L., and Cheung K., “Effectiveness of educational interventions on adherence to lifestyle modifications among hypertensive patients: An integrative review,” International Journal of Environmental Research and Public Health, vol. 17, no. 17, pp. 1–18, 2020.

[18] Treciokiene I., Postma M., Nguyen T., Fens T., Petkevicius J., Kubilius R., Gulbinovic J., and Taxis K., “Healthcare professional-led interventions on lifestyle modifications for hypertensive patients: A systematic review and meta-analysis,” BMC Primary Care, vol. 22, no. 135, pp. 1–13, 2021.

[19] Ha N. T., Duy H. T., Le N. H., Khanal V., and Moorin R., “Quality of life among people living with hypertension in a rural Vietnam community,” BMC Public Health, vol. 14, no. 1, pp. 1–9, 2014.

[20] Saleem F., Hassali M. A., Shafie A. A., Haq N., Aljadhey H., and Atif M., “Does pharmacist-led educational intervention improve health-related quality of life among hypertensive patients? A non-clinical randomized controlled trial,” Health Expect., vol. 18, no. 5, pp. 1270–1281, 2015.